|
Name |
2,3',6-Trihydroxy-4'-methoxybenzylcoumaranone
|
Molecular Formula | C16H14O6 | |
IUPAC Name* |
2,6-dihydroxy-2-[(3-hydroxy-4-methoxyphenyl)methyl]-1-benzofuran-3-one
|
|
SMILES |
COC1=C(C=C(C=C1)CC2(C(=O)C3=C(O2)C=C(C=C3)O)O)O
|
|
InChI |
InChI=1S/C16H14O6/c1-21-13-5-2-9(6-12(13)18)8-16(20)15(19)11-4-3-10(17)7-14(11)22-16/h2-7,17-18,20H,8H2,1H3
|
|
InChIKey |
HBEFLXKTZCXMQU-UHFFFAOYSA-N
|
|
Synonyms |
2,3',6-Trihydroxy-4'-methoxybenzylcoumaranone; 2,6,3'-Trihydroxy-4'-methoxy-2-benzylcoumaranone; CHEBI:174886; LMPK12130066; 2,6-dihydroxy-2-[(3-hydroxy-4-methoxyphenyl)methyl]-1-benzouran-3-one
|
|
CAS | NA | |
PubChem CID | 42607789 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 302.28 | ALogp: | 2.0 |
HBD: | 3 | HBA: | 6 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 96.2 | Aromatic Rings: | 3 |
Heavy Atoms: | 22 | QED Weighted: | 0.804 |
Caco-2 Permeability: | -4.73 | MDCK Permeability: | 0.00001450 |
Pgp-inhibitor: | 0.006 | Pgp-substrate: | 0.054 |
Human Intestinal Absorption (HIA): | 0.015 | 20% Bioavailability (F20%): | 0.048 |
30% Bioavailability (F30%): | 0.626 |
Blood-Brain-Barrier Penetration (BBB): | 0.087 | Plasma Protein Binding (PPB): | 94.41% |
Volume Distribution (VD): | 0.639 | Fu: | 3.63% |
CYP1A2-inhibitor: | 0.837 | CYP1A2-substrate: | 0.721 |
CYP2C19-inhibitor: | 0.519 | CYP2C19-substrate: | 0.211 |
CYP2C9-inhibitor: | 0.53 | CYP2C9-substrate: | 0.884 |
CYP2D6-inhibitor: | 0.504 | CYP2D6-substrate: | 0.881 |
CYP3A4-inhibitor: | 0.813 | CYP3A4-substrate: | 0.478 |
Clearance (CL): | 13.852 | Half-life (T1/2): | 0.884 |
hERG Blockers: | 0.036 | Human Hepatotoxicity (H-HT): | 0.043 |
Drug-inuced Liver Injury (DILI): | 0.736 | AMES Toxicity: | 0.189 |
Rat Oral Acute Toxicity: | 0.065 | Maximum Recommended Daily Dose: | 0.039 |
Skin Sensitization: | 0.492 | Carcinogencity: | 0.132 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.045 |
Respiratory Toxicity: | 0.06 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000940 | 0.587 | D07MGA | 0.435 | ||||
ENC002584 | 0.458 | D06TJJ | 0.343 | ||||
ENC000700 | 0.435 | D0Q9ON | 0.326 | ||||
ENC005357 | 0.417 | D0E9CD | 0.319 | ||||
ENC001771 | 0.412 | D0U3YB | 0.315 | ||||
ENC001848 | 0.400 | D0AZ8C | 0.314 | ||||
ENC003721 | 0.394 | D06GCK | 0.313 | ||||
ENC001573 | 0.386 | D04UTT | 0.311 | ||||
ENC003492 | 0.383 | D0J7RK | 0.309 | ||||
ENC001438 | 0.376 | D00CSQ | 0.301 |